Login / Signup
ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.
Tejashree Joglekar
Jianqing Lin
Maho Shibata
Published in:
Expert opinion on therapeutic targets (2020)
Keyphrases
</>
combination therapy